Aap Implantate AG annual ebitda margin
2021
2022
2023
2024
2025
Aap Implantate AG's ebitda margin was −5.10% for fiscal 2025.
View full Aap Implantate AG company overview| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −5.10% | +1.90 pp |
| 2024 | 2024-12-31 | −7.00% | +22.89 pp |
| 2023 | 2023-12-31 | −29.89% | −15.01 pp |
| 2022 | 2022-12-31 | −14.88% | −8.59 pp |
| 2021 | 2021-12-31 | −6.30% | — |
Between the periods ended 2021-12-31 and 2025-12-31, Aap Implantate AG's ebitda margin increased from −6.30% to −5.10%, a change of +1.19 percentage points.
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aap Implantate AG source filings ↗